Cera Funding: How Much Did They Raise & Key Investors

How Much Did Cera Raise?
Funding & Key Investors

Cera, a prominent player in the digital health sector, has successfully secured a total of $327M in capital to accelerate its mission of transforming home-based care. The most recent strategic investment of $320M marks a significant milestone in the company's trajectory, signaling robust investor confidence in its proprietary technology platform and operational model. This infusion of financing underscores the growing demand for scalable, tech-enabled healthcare solutions that allow patients to receive high-quality medical support within the comfort of their own homes.

Since its inception in 2016, Cera has navigated multiple rounds of backing, evolving from its initial Series A phase to its current status as a major enterprise-level entity. This growth trajectory reflects the company's ability to integrate complex logistics with clinical care, effectively bridging the gap between traditional healthcare providers and modern digital infrastructure.

What is Cera?

Cera

Healthcare Services

Elderly Care Services

Headquartered in London, Cera operates at the intersection of health-tech and social care. By leveraging data-driven insights and a sophisticated digital platform, the company provides comprehensive in-home health services. Its core value proposition lies in its ability to optimize care delivery, reduce hospital readmission rates, and provide a sustainable alternative to institutionalized care. As the global population ages, Cera's market position as a tech-forward care provider becomes increasingly critical, positioning it as a leader in the digital transformation of the healthcare industry.

How much funding has Cera raised?

Cera has raised a total of $327M across 2 funding rounds:

2020

Series A

$7M

2022

Other Financing Round

$320M

Series A (2020): $7M with participation from Atlantic Labs, Asabys Partners Company, and JJDC , Inc.

Other Financing Round (2022): $320M led by KairosHQ, Jane Street Capital, and Schroders Capital

Key Investors in Cera

Atlantic Labs

A Berlin-based venture capital firm that specializes in early-stage investments, focusing on digital health and technology-driven business models.

Schroders Capital

A global investment management firm providing private equity and venture capital solutions to support the growth of innovative, high-impact enterprises.

Jane Street Capital

A quantitative trading firm and institutional investor known for its rigorous analytical approach to identifying high-growth opportunities across diverse sectors.

What's next for Cera?

With the recent influx of capital, Cera is well-positioned to scale its operations and deepen its technological moat. The company is expected to focus on expanding its geographic footprint and enhancing its predictive analytics capabilities to further personalize patient care. By prioritizing the integration of artificial intelligence into its care-coordination workflows, Cera aims to improve operational efficiency while maintaining high standards of clinical outcomes. This strategic expansion will likely involve further investment in talent acquisition and the development of new service lines, ensuring the company remains at the forefront of the home-care revolution.

See full Cera company page

See More Financial Insights